{"filing":{"accession_number":"0001213900-26-088681","cik":"0001854587","ticker":"CLBT","company_name":"Cellebrite DI Ltd.","form":"6-K","filing_date":"2026-08-13","report_date":"2026-08-13","primary_document":"ea0301880-6k_cellebrite.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1854587/000121390026088681/ea0301880-6k_cellebrite.htm"},"events":[{"id":27483,"run_id":25054,"accession_number":"0001213900-26-088681","anchor_item_number":"EX-99.1","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"This press release announces Cellebrite's second-quarter 2026 financial results, including ARR of $507.8M (up 21% YoY), revenue of $131.1M (up 16% YoY), and adjusted EBITDA of $31.8M. While the release also discloses a CEO succession (Shiven Ramji succeeding Thomas E. Hogan), the primary substance is the earnings announcement with detailed financial metrics and forward guidance. The company explicitly \"lowered full-year 2026 ARR and revenue outlook\" while raising adjusted EBITDA targets, making the financial results the dominant disclosure. The CEO transition, though material, is secondary to the earnings content.","company_name":"Cellebrite DI Ltd.","ticker":"CLBT","filing_date":"2026-08-13","form":"6-K","submitted_at":null,"items":[{"id":29048,"accession_number":"0001213900-26-088681","item_number":"EX-99.1","item_title":"ea030188001ex99-1.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"This press release announces Cellebrite's second-quarter 2026 financial results, including ARR of $507.8M (up 21% YoY), revenue of $131.1M (up 16% YoY), and adjusted EBITDA of $31.8M. While the release also discloses a CEO succession (Shiven Ramji succeeding Thomas E. Hogan), the primary substance is the earnings announcement with detailed financial metrics and forward guidance. The company explicitly \"lowered full-year 2026 ARR and revenue outlook\" while raising adjusted EBITDA targets, making the financial results the dominant disclosure. The CEO transition, though material, is secondary to the earnings content.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-13T11:16:42.232014+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":29048,"accession_number":"0001213900-26-088681","item_number":"EX-99.1","item_title":"ea030188001ex99-1.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"This press release announces Cellebrite's second-quarter 2026 financial results, including ARR of $507.8M (up 21% YoY), revenue of $131.1M (up 16% YoY), and adjusted EBITDA of $31.8M. While the release also discloses a CEO succession (Shiven Ramji succeeding Thomas E. Hogan), the primary substance is the earnings announcement with detailed financial metrics and forward guidance. The company explicitly \"lowered full-year 2026 ARR and revenue outlook\" while raising adjusted EBITDA targets, making the financial results the dominant disclosure. The CEO transition, though material, is secondary to the earnings content.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-13T11:16:42.232014+00:00","company_name":"Cellebrite DI Ltd.","ticker":"CLBT","filing_date":"2026-08-13"}]}